British Journal of Medical & Surgical Urology
Volume 1, Issue 1 , Pages 25-30 , July 2008

Age-specific PSA reference values based on a screening population of British men

  • M.H. Winkler

      Affiliations

    • Department of Urology, Imperial College Healthcare NHS Trust, London, UK
    • Corresponding Author InformationCorresponding author at: Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, UK.
    • ,
  • E.K. Mayer

      Affiliations

    • Department of Urology, Imperial College Healthcare NHS Trust, London, UK
    • ,
  • A. Carter

      Affiliations

    • Department of Urology, Royal Gwent Hospital, Newport, Gwent, UK
    • ,
  • E. Kulinskaya

      Affiliations

    • Statistical Advisory Service, Imperial College London, UK
    • ,
  • J.S.A. Green

      Affiliations

    • Department of Urology, Whipps Cross Hospital, London, UK

References 

  1. Melia J, Moss S, Johns L. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int. 2004;94(1):51–56
  2. BAUS Cancer Registry; 2002.
  3. The NHS Cancer Plan. Department of Health; 2000 [Accessed February 2007] http://www.dh.gov.uk/assetRoot/04/01/45/13/04014513.pdf.
  4. Referral Guidelines for Suspected Cancer. Department of Health; 2000 [Accessed February 2007] http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4008746&chk=jtsIsg.
  5. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer; 2005 [Accessed February 2007] http://www.nice.org.uk/guidance/index.jsp?action=download&o=29814.
  6. Prostate Cancer Risk Management: UK Information Pack. NHS Cancer Screening Programme; 2002 [Accessed February 2007] http://www.cancerscreening.nhs.uk/prostate/informationpack.html.
  7. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med. 1996;335(5):304–310
  8. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol. 1995;75(3):347–353
  9. Green JS, Holden ST, Bose P, George DP, Bowsher WG. An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction. Int J Impot Res. 2001;13(6):322–325
  10. Marazzi A, Yohai VJ. Adaptively truncated maximum likelihood regression with asymmetric errors. J Stat Plan Infer. 2004;122(1–2):271–291
  11. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology. 1999;53(3):581–589
  12. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826–830
  13. Oesterling JE, Jacobsen SJ, Cooner WH. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J Urol. 1995;153(4):1160–1163
  14. Parker C, Muston D, Melia J, Moss S, Dearnaley D. A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer. 2006;94(10):1361–1368
  15. Borer JG, Sherman J, Solomon MC, Plawker MW, Macchia RJ. Age specific prostate specific antigen reference ranges: population specific. J Urol. 1998;159(2):444–448
  16. Bassler TJ, Orozco R, Bassler IC, O’Dowd GJ, Stamey TA. Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant. Urology. 1998;52(6):1064–1069
  17. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151(5):1283–1290
  18. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. Jama. 1993;270(7):860–864
  19. Lofman O, Lindahl T, Varenhorst E. Age-specific reference values for serum prostate-specific antigen in a community-based population of healthy Swedish men. Scand J Clin Lab Invest. 1997;57(3):225–232
  20. Kalish LA, McKinlay JB. Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA. Urology. 1999;54(6):1022–1027
  21. Anderson JR, Strickland D, Corbin D, Byrnes JA, Zweiback E. Age-specific reference ranges for serum prostate-specific antigen. Urology. 1995;46(1):54–57

PII: S1875-9742(08)00007-4

doi: 10.1016/j.bjmsu.2008.05.006

British Journal of Medical & Surgical Urology
Volume 1, Issue 1 , Pages 25-30 , July 2008

Article Tools